This company listing is no longer active
TTB Stock Overview
Total Brain Limited operates as an applied integrative neuroscience company in the United States and Australia.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Total Brain Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.002 |
| 52 Week High | AU$0.13 |
| 52 Week Low | AU$0.001 |
| Beta | 1.37 |
| 1 Month Change | -95.74% |
| 3 Month Change | -95.00% |
| 1 Year Change | -98.26% |
| 3 Year Change | -99.60% |
| 5 Year Change | -99.60% |
| Change since IPO | -99.93% |
Recent News & Updates
Shareholder Returns
| TTB | AU Healthcare | AU Market | |
|---|---|---|---|
| 7D | 0% | 2.2% | 0.9% |
| 1Y | -98.3% | -21.8% | 5.6% |
Return vs Industry: TTB underperformed the Australian Healthcare industry which returned -5.9% over the past year.
Return vs Market: TTB underperformed the Australian Market which returned -1.5% over the past year.
Price Volatility
| TTB volatility | |
|---|---|
| TTB Average Weekly Movement | 37.5% |
| Healthcare Industry Average Movement | 6.8% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in AU Market | 17.6% |
| 10% least volatile stocks in AU Market | 3.5% |
Stable Share Price: TTB's share price has been volatile over the past 3 months.
Volatility Over Time: TTB's weekly volatility has increased from 24% to 38% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | n/a | Matt Mund | www.totalbrain.com |
Total Brain Limited operates as an applied integrative neuroscience company in the United States and Australia. The company offers Total Brain, a mental health monitoring and support platform, that helps users to measure their brain capacities while managing the risk of common mental conditions. It serves companies, providers, affinity groups, and precision medicine sectors.
Total Brain Limited Fundamentals Summary
| TTB fundamental statistics | |
|---|---|
| Market cap | AU$267.44k |
| Earnings (TTM) | -AU$14.50m |
| Revenue (TTM) | AU$8.42m |
0.0x
P/S Ratio0.0x
P/E RatioIs TTB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TTB income statement (TTM) | |
|---|---|
| Revenue | AU$8.42m |
| Cost of Revenue | AU$10.25m |
| Gross Profit | -AU$1.84m |
| Other Expenses | AU$12.66m |
| Earnings | -AU$14.50m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.11 |
| Gross Margin | -21.81% |
| Net Profit Margin | -172.26% |
| Debt/Equity Ratio | 11.8% |
How did TTB perform over the long term?
See historical performance and comparison